Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.62
69% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2025 | |
|---|---|
| Revenue | $6.5M |
| Cost of revenue | $0 |
| Gross profit | $6.5M |
| Gross margin | 100.0% |
| R&D | $0 |
| Operating income | −$233.4M |
| EBITDA | −$440.5M |
| Net income | −$450.5M |
| Net margin | -6881.3% |
| EPS (diluted) | -55.18 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $30M | $57.00 | $57.00–$57.00 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ATNFW.
No tracked institution reports a position in ATNFW as of their last filing.
No one on the platform has traded ATNFW yet.
| $12M |
| — |
| MDVLMedAvail Holdings, Inc. | $1.80 | -43.22% | $3M | — |
| NOVNNovan, Inc. | $0.09 | -24.84% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.